By Grant J. Anhalt, M.D. and Hossein Nousari, M.D.Johns Hopkins University, School of Medicine In February 1997, the FDA approved a new drug, mycophenolate mofetil (MFM, also known as Cellcept) with an approved indication for use in immunosuppression of patients…
- Главная страница
- О нас
- Живущих с P/P
- Научные исследования
- Принять участие
- Новости & Информация о
- Discussion Forums
